Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial
Titel:
Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial
Auteur:
Schuster, Antje Caimmi, Davide Nolte, Hendrik Novakova, Silviya Mikler, Jan Foss-Skiftesvik, Majken Hougaard Ă˜sterdal, Anne Sofie Emeryk, Andrzej Gagnon, Remi Pfaar, Oliver